Why C4 Therapeutics, Inc. (CCCC) stock fell 8.1% intraday on Thursday, November 12, 2026

C4 Therapeutics, Inc. (CCCC) traded at $2.66 as of 11:31 AM ET, down 8.13% on Thursday, November 12, 2026, on volume of 940,983 shares (0.4× its 3-month average); market value about $300.0M, according to Nexqual market data (nexqual.com/moves/2026-11-12/CCCC).

CCCC was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for CCCC on Thursday, November 12, 2026 or the trading day before (November 11, 2026), each linked to its primary source:

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on CCCC

CCCC stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 12, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:48 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 18, 2026 at 20:48 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt